Hormone therapy against prostate cancer risk? | 96band.com ...

A higher risk of heart attack and sudden cardiac death have also been observed in men who have used GnRH agonists for a short period, but these results may be due to chance.Keating team did not affect men at any special treatment. Instead, researchers have simply noticed hormonal therapy in men.

The odds of having a heart attack, sudden death, or new coronary heart disease are not associated with the removal of the testicles. Study limitations

These include Nancy Keating, MD, MPH, Department of health care policy at Harvard Medical. Their study appears in the Journal of Clinical Oncology.

Are you getting all the information needed to manage your prostate cancer? Obtain health information needed by WebMD, your trusted source for health.

Mr. Gupta said more research is needed to understand the differences in the risk of pancreatic cancer among men and women and to understand why the excessive use of alcohol and binge drinking may increase the risk of pancreatic cancer in men.

The men were all at least 66 years . They had a local or regional prostate cancer, or cancer had not spread beyond the prostate.

Keating and his colleagues examined the medical records of more than 73,000 men enrolled in Medicare who have been diagnosed with prostate cancer between 1992 and 1999.

Hormone therapy for prostate cancer may be a sudden death, myocardial infarction, coronary artery disease and diabetes is more likely, a new study.

Men undergoing orchiectomy were 34 percent more likely to develop diabetes than those who do not have access to care.

The researchers followed the men of about 4.5 years on average. In the meantime:

The study does not prove that anti-androgen therapy was responsible for diabetes, heart disease, heart attack or sudden death in any patient.

Further studies are needed to be sure of this. Meanwhile, men with prostate cancer and their physicians must weigh the risks and benefits of such treatment, the researchers say.

During follow-up, diabetes was diagnosed in 11 percent of men who did not have diabetes when the study began.

The higher risk of diagnosis of diabetes and coronary heart disease ?was evident in men treated with GnRH agonists for a minimum of 1-4 months,? the researchers write.

During the study, men who received a GnRH agonist were 16 percent more likely to die of sudden cardiac death, 11 percent more likely to have a heart attack, 16 percent more likely to be diagnosed with coronary artery disease and 44 percent more likely to be diagnosed with diabetes than those without any treatment.

Source: http://96band.com/hormone-therapy-against-prostate-cancer-risk/

daylight savings time john mccain game changer selection sunday corned beef recipe time change daylight savings